Depresszió: vizsgálatok itt: Bulgária
13 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Where
- Lovech, Plovdiv, Sofia
- Életkor
- 18 év to 65 év
- People
- 360 worldwide
- Run by
- Seaport Therapeutics
See details and how to joinNCT07065240 · EU 2025-521240-37-00 - 2. fázisCsak meghívásosAn Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)
- Where
- Lovech, Plovdiv, Sofia
- Életkor
- 18 év to 66 év
- People
- 360 worldwide
- Run by
- Seaport Therapeutics
See details and how to joinNCT07161700 · EU 2025-522347-18-00 - 2. fázisNot yet taking people in BulgáriaA Study of Brenipatide in Participants With Major Depressive Disorder
- Where
- Pleven, Plovdiv, Sofia, Varna, Vratsa
- Életkor
- 18 év to 75 év
- People
- 330 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07928245 · EU 2026-527689-65-00 - 3. fázisTaking peopleA research study to compare the antidepressant ability and safety of Samyr® tablets versus placebo tablets as an adjunct to additional antidepressant treatment in patients with major depressive disorder (MDD)
- Where
- Cherven Bryag, Plovdiv, Ruse, Sofia, Sofiya, Vratsa
- Életkor
- 18 év and over
- People
- 868 worldwide
- Run by
- Mylan Inc.
See details and how to join2024-513019-29-00 · EU 2024-513019-29-00 - 3. fázisTaking peopleStudy of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Where
- Cherven Bryag, Kirdzhali, Pleven, Plovdiv, Sofia, Sofiya, Stara Zagora, Varna
- Életkor
- 18 év to 65 év
- People
- 470 worldwide
- Run by
- Intra-Cellular Therapies, Inc.
See details and how to joinNCT05850689 · EU 2023-503836-41-00 - 3. fázisTaking peoplePhase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Where
- Burgas, Plovdiv, Sofia, Sofiya, Stara Zagora, Varna
- Életkor
- 18 év to 74 év
- People
- 752 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06559306 · EU 2023-509070-36-00 - 3. fázisTaking peopleLong-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Where
- Kirdzhali, Plovdiv, Ruse, Sofia, Sofiya, Varna
- Életkor
- 18 év and over
- People
- 850 worldwide
- Run by
- Neurocrine Biosciences
See details and how to joinNCT06966401 · EU 2024-519423-24-00 - 3. fázisTaking peopleA Study to Evaluate the Maintenance Effect of Osavampator as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Where
- Sofia, Sofiya, Varna
- Életkor
- 18 év and over
- People
- 550 worldwide
- Run by
- Neurocrine Biosciences
See details and how to joinNCT07196501 · EU 2025-520541-72-00 - 2. fázisTaking peopleA Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Where
- Kazanlak, Plovdiv, Sofia, Vratsa
- Életkor
- 18 év to 75 év
- People
- 300 worldwide
- Run by
- Draig Therapeutics Ltd
See details and how to joinNCT07300969 - 3. fázisTaking peopleEvaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Where
- Kirdzhali, Pleven, Plovdiv, Sofia, Targovishte, Varna, Vratsa
- Életkor
- 18 év to 65 év
- People
- 500 worldwide
- Run by
- Vanda Pharmaceuticals
See details and how to joinNCT06830044 · EU 2024-520333-68-00 - 2. fázisTaking peopleDT-101 in Adults with Major Depressive Disorder
- Where
- Cherven Bryag, Kazanlik, Plovdiv, Sofia, Sofiya, Vratsa
- Életkor
- 18 év and over
- People
- 175 worldwide
- Run by
- Draig Therapeutics Limited
See details and how to join2025-522784-15-00 · EU 2025-522784-15-00 - 3. fázisTaking peopleNBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Where
- Kirdzhali, Plovdiv, Ruse, Sofiya, Varna
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- Neurocrine Biosciences
See details and how to joinNCT06911112 · EU 2024-519420-25-00 - 4. fázisNot yet taking people in BulgáriaEvaluation of the efficacy of Trazodone in improving emotional blunting symptoms in Patients with Major Depressive Disorder
- Where
- Kazanlik, Plovdiv, Sofia
- Életkor
- 18 év to 64 év
- People
- 120 worldwide
- Run by
- Angelini Pharma Italia Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. Enunciabile Anche Angelini Pharma Italia S.p.A. Angelini Pharma S.p.A. A.C.R.A.F. S.p.A. Acraf S.p.A. Angelini S.p.A. aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A.
See details and how to join2025-523267-38-00 · EU 2025-523267-38-00